Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care
Thursday, August 18, 2022
OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the high-performance OptraSCAN Digital pathology platform to enhance care for their patient population. The capabilities of this digital pathology platform improve accessibility to healthcare and the distributed care model.
The demand for digital pathology has increased as healthcare institutions have struggled to overcome the challenges of the traditional care model of pathologists working in labs with physical microscopes. These workflow problems have been intensified by a shrinking pathologist population at the same time as biopsy rates have increased along with increased cancer screening options. Digital pathology facilitates remote consultations and second opinions to arrive at a diagnosis and initiate cancer treatment more rapidly.
Dr. Ajit Nambiar, Director & Head, Pathology and Lab Medicine at Karkinos Healthcare, explained, "We plan to provide the best possible care to our patients and adoption of OptraSCAN digital pathology solution is an important step in that direction. OptraSCAN is a very capable solution provider, and we are very happy to partner with them."
The synergies between the two organizations and potential efficiencies were echoed by Mr. Abhi Gholap, Founder & CEO, OptraSCAN, as he stated, "Instant second opinions, remote reporting and permanent digital storage of patient slides are some of the benefits of digital pathology. We eagerly look forward to facilitating them for Karkinos Healthcare. OptraSCAN has seen increasing sales across the world as more organizations adopt their affordable products and services. With 250% growth in our year-to-year global sales revenues, OptraSCAN is a preferred vendor of many small to large laboratories and hospitals worldwide."
Karkinos Healthcare is pioneering the Distributed Cancer Care Network model in India addressing clinical needs of cancer patients, with a focus on early detection of cancer. The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing care closer to patients backed by a robust technology platform. Karkinos already offers its services in the states of Kerala, Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Maharashtra, Madhya Pradesh, West Bengal, Manipur, Delhi NCR and is planning to ramp up its operations across India. The company is a member of National Cancer Grid, a group of 260+ cancer focused institutions. Karkinos Healthcare is also setting up a Cancer Centre in Jawaharlal Nehru Institute of Medical Sciences (JNIMS) premises at Imphal, in partnership with the Government of Manipur.